The identification of two de novo gain-of-function missense mutations in CACNA1D in two patients with primary aldosteronism, seizures and neurological abnormalities (PASNA, OMIM: 615474) (11), further points to the involvement of altered Cav1.3 function in neurological disorders. The gene discussed is CACNA1D; the disease is nervous system disorder.